ResearcherOsaka International Cancer InstituteActive in the last 2 years
Manabu Mikamori
Matched on ORCID iD 0000-0002-6671-2698; OpenAlex author ID A5065731431. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 2 papers · 2024: 2 papers
Papers 5
- Clinical impact of high-quality testing for peritoneal lavage cytology in pancreatic cancer. Co-author DOI 10.1038/s41598-024-60936-4↗
- Portal vein wedge resection and patch venoplasty with autologous vein grafts for hepatobiliary-pancreatic cancer. Co-author DOI 10.1186/s40792-024-01823-y↗
- DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderline resectable pancreatic cancer. Co-author DOI 10.1186/s12885-023-10512-2↗
- [A Case Report-A Successful Case of Distal Pancreatectomy with En Bloc Celiac Axis Resection for Locally Advanced Pancreatic Cancer with an Aberrant Right Hepa… Co-author PMID 36927906↗
- MicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1038/srep42339↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tadafumi Asaoka · 4 shared papers, 2017–2024 · strength 0.61
- Paper Clinical impact of high-quality testing for peritoneal lavage cytology in pancreatic cancer. DOI 10.1038/s41598-024-60936-4↗
- Paper Portal vein wedge resection and patch venoplasty with autologous vein grafts for hepatobiliary-pancreatic cancer. DOI 10.1186/s40792-024-01823-y↗
- Paper [A Case Report-A Successful Case of Distal Pancreatectomy with En Bloc Celiac Axis Resection for Locally Advanced Pancr… PMID 36927906↗
- Kenta Furukawa · 3 shared papers, 2023–2024 · strength 0.55
- Paper Clinical impact of high-quality testing for peritoneal lavage cytology in pancreatic cancer. DOI 10.1038/s41598-024-60936-4↗
- Paper Portal vein wedge resection and patch venoplasty with autologous vein grafts for hepatobiliary-pancreatic cancer. DOI 10.1186/s40792-024-01823-y↗
- Paper [A Case Report-A Successful Case of Distal Pancreatectomy with En Bloc Celiac Axis Resection for Locally Advanced Pancr… PMID 36927906↗
- Daisaku Yamada · 3 shared papers, 2017–2024 · strength 0.40
- Paper Clinical impact of high-quality testing for peritoneal lavage cytology in pancreatic cancer. DOI 10.1038/s41598-024-60936-4↗
- Paper DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderli… DOI 10.1186/s12885-023-10512-2↗
- Paper MicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma. DOI 10.1038/srep42339↗
- Satoshi Hyuga · 2 shared papers, 2023–2024 · strength 0.34
- Tomofumi Ohashi · 2 shared papers, 2023–2024 · strength 0.34
- Tsunekazu Mizushima · 2 shared papers, 2023–2024 · strength 0.34
- Masahiro Tanemura · 2 shared papers, 2017–2024 · strength 0.27
- Hidetoshi Eguchi · 2 shared papers, 2017–2024 · strength 0.27
- Daiki Marukawa · 1 shared paper, 2024 · strength 0.21
- Shinichiro Hasegawa · 2 shared papers, 2017–2023 · strength 0.19
- Paper DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderli… DOI 10.1186/s12885-023-10512-2↗
- Paper MicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma. DOI 10.1038/srep42339↗
- Masato Sakon · 1 shared paper, 2023 · strength 0.13
- Hirofumi Akita · 1 shared paper, 2023 · strength 0.13
- Yosuke Mukai · 1 shared paper, 2023 · strength 0.13
- Osamu Ishikawa · 1 shared paper, 2023 · strength 0.13
- Hidenori Takahashi · 1 shared paper, 2023 · strength 0.13
- Yuichiro Doki · 1 shared paper, 2017 · strength 0.06
- Yoshito Tomimaru · 1 shared paper, 2017 · strength 0.06
- Kunihito Gotoh · 1 shared paper, 2017 · strength 0.06
- Yutaka Takeda · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.